Not the End of the Odyssey: Parental Perceptions of Whole Exome Sequencing (WES) in Pediatric Undiagnosed Disorders

Journal of Genetic Counseling

Volumn 25, Issue 5, 2016, Pages 1019-1031

  Rosell, Allyn McConkie ^a   Pena, Loren D M ^a   Schoch, Kelly ^a   Spillmann, Rebecca ^a   Sullivan, Jennifer ^a   Hooper, Stephen R ^b   Jiang, Yong Hui ^a   Mathey Andrews, Nicolas ^a   Goldstein, David B ^c   Shashi, Vandana ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Department of Medicine   (United States)

Author keywords

Empowerment; Genetic counseling; Parental perspectives; Whole exome sequencing

Indexed keywords

ADULT; EXOME; FEMALE; GENETIC DISORDER; GENETIC SCREENING; GENETICS; HUMAN; INTERPERSONAL COMMUNICATION; MALE; MIDDLE AGED; MOTIVATION; PARENT; PEDIATRICS; PSYCHOLOGY; RARE DISEASE; RETROSPECTIVE STUDY; SEQUENCE ANALYSIS;

ADULT; COMMUNICATION; DISCLOSURE; EXOME; FEMALE; GENETIC DISEASES, INBORN; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; MOTIVATION; PARENTS; PEDIATRICS; RARE DISEASES; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS;

EID: 84957656120     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-016-9933-1     Document Type: Article

References (37)

1. Abdul-Karim, R., Berkman, B. E., Wendler, D., Rid, A., Khan, J., Badgett, T., & Hull, S. C. (2013). Disclosure of Incidental Findings from next-Generation Sequencing in Pediatric Genomic Research. Pediatrics, 131(3), 564–571. doi:10.1542/peds.2012-0084.
2. Angrist, M. (2011). You Never Call, you Never Write: Why Return of 'Omic' Results to Research Participants is Both a Good Idea and a Moral Imperative. Per Med, 8(6), 651–657. doi:10.2217/pme.11.62.
3. Ashtiani, S., Makela, N., Carrion, P., & Austin, J. (2014). Parents' experiences of receiving their child's genetic diagnosis: a qualitative study to inform clinical genetics practice. Am J Med Genet A, 164a(6), 1496–1502. doi:10.1002/ajmg.a.36525.
4. Bergner, A. L., Bollinger, J., Raraigh, K. S., Tichnell, C., Murray, B., Blout, C. L., et al. (2014). Informed consent for exome sequencing research in families with genetic disease: the emerging issue of incidental findings. Am J Med Genet A, 164a(11), 2745–2752. doi:10.1002/ajmg.a.36706.
5. Campbell, J. L., Quincy, C., Osserman, J., & Pedersen, O. K. (2013). Coding In-Depth Semistructured Interviews: Problems of Unitization and Intercoder Reliability and Agreement. Sociological Methods & Research, 42(3), 294–320. doi:10.1177/0049124113500475.
6. Clayton, E. W., & McGuire, A. L. (2012). The Legal Risks of Returning Results of Genomics Research. Genetics in Medicine, 14(4), 473–477. doi:10.1038/gim.2012.10.
7. Clift, K. E., Halverson, C. M. E., Fiksdal, A. S., Kumbamu, A., Sharp, R. R., & McCormick, J. B. (2015). Patients' Views on Incidental Findings from Clinical Exome Sequencing. Applied & Translational Genomics, 4, 38–43. doi:10.1016/j.atg.2015.02.005.
8. Dunst, C. J., & Paget, K. D. (1991). Parent-professional partnerships and family empowerment. In M. Fine (Ed.), Collaboration with parents of exceptional children (pp. 25–44). Brandon, VT: Clinical Psychology Publishing.
9. Enns, G. M., Shashi, V., Bainbridge, M., Gambello, M. J., Zahir, F. R., Bast, T., et al. (2014). Mutations in NGLY1 Cause an Inherited Disorder of the Endoplasmic Reticulum-Associated Degradation Pathway. Genetics in Medicine, 16(10), 751–758. doi:10.1038/gim.2014.22.
10. Facio, F. M., Lee, K., & O'Daniel, J. M. (2014). A Genetic Counselor's Guide to Using next-Generation Sequencing in Clinical Practice. Journal of Genetic Counseling, 23(4), 455–462. doi:10.1007/s10897-013-9662-7.
11. Fernandez, C., Bouffet, E., Malkin, D., Jabado, N., O'Connell, C., Avard, D., et al. (2014). Attitudes of parents toward the return of targeted and incidental genomic research findings in children. Genetics in Medicine, 16(8), 633–640. doi:10.1038/gim.2013.201.
12. Gilissen, C., Hoischen, A., Brunner, H. G., & Veltman, J. A. (2011). Unlocking Mendelian Disease Using Exome Sequencing. Genome Biology, 12(9), 228. doi:10.1186/gb-2011-12-9-228.
13. Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., et al. (2013). ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing. Genetics in Medicine, 15(7), 565–574. doi:10.1038/gim.2013.73.
14. Hegde, M., Bale, S., Bayrak-Toydemir, P., Gibson, J., Jeng, L. J., Joseph, L., et al. (2015). Reporting Incidental Findings in Genomic Scale Clinical Sequencing–a Clinical Laboratory Perspective: A Report of the Association for Molecular Pathology. The Journal of Molecular Diagnostics, 17(2), 107–117. doi:10.1016/j.jmoldx.2014.10.004.
15. Jarvik, G. P., Amendola, L. M., Berg, J. S., Brothers, K., Clayton, E. W., Chung, W., et al. (2014). Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between. American Journal of Human Genetics. doi:10.1016/j.ajhg.2014.04.009.
16. Krabbenborg, L., Schieving, J., Kleefstra, T., Vissers, L. E., Willemsen, M. A., Veltman, J. A., & van der Burg, S. (2016) Evaluating a counselling strategy for diagnostic WES in paediatric neurology: an exploration of parents' information and communication needs. Clinical Genetics, 89 (2), 244-250 doi:10.1111/cge.12601
17. Lambertson, K. F., Damiani, S. A., Might, M., Shelton, R., & Terry, S. F. (2015). Participant-Driven Matchmaking in the Genomic Era. Human Mutation. doi:10.1002/humu.22852.
18. Lee, H., Deignan, J. L., Dorrani, N., & et al. (2014). Clinical Exome Sequencing for Genetic Identification of Rare Mendelian Disorders. Journal of the American Medical Association doi:10.1001/jama.2014.14604
19. Maxwell, J. (1996). Qualitative research design: An interactive approach (vol. 41,). Thousand Oaks, London, New Delhi: Sage.
20. McAllister, M., Davies, L., Payne, K., Nicholls, S., Donnai, D., & MacLeod, R. (2007). The Emotional Effects of Genetic Diseases: Implications for Clinical Genetics. American Journal of Medical Genetics. Part A, 143A(22), 2651–2661. doi:10.1002/ajmg.a.32013.
21. McAllister, M., Payne, K., Macleod, R., Nicholls, S., Dian, D., & Davies, L. (2008a). Patient Empowerment in Clinical Genetics Services. Journal of Health Psychology, 13(7), 895–905. doi:10.1177/1359105308095063.
22. McAllister, M., Payne, K., Macleod, R., Nicholls, S., Donnai, D., & Davies, L. (2008b). What Process Attributes of Clinical Genetics Services Could Maximise Patient Benefits? European Journal of Human Genetics, 16(12), 1467–1476. doi:10.1038/ejhg.2008.121.
23. McAllister, M., Wood, A. M., Dunn, G., Shiloh, S., & Todd, C. (2011). The Genetic Counseling Outcome Scale: A new Patient-Reported Outcome Measure for Clinical Genetics Services. Clinical Genetics, 79(5), 413–424. doi:10.1111/j.1399-0004.2011.01636.x.
24. McConkie-Rosell, A., & Sullivan, J. A. (1999). Genetic Counseling-Stress, Coping, and the Empowerment Perspective. Journal of Genetic Counseling, 8(6), 345–357. doi:10.1023/a:1022919325772.
25. McConkie-Rosell, A., Robinson, H., Wake, S., Staley, L. W., Heller, K., & Cronister, A. (1995). Dissemination of Genetic Risk Information to Relatives in the Fragile X Syndrome: Guidelines for Genetic Counselors. American Journal of Medical Genetics, 59(4), 426–430. doi:10.1002/ajmg.1320590406.
26. McConkie-Rosell, A., Del Giorno, J., & Heise, E. M. (2011). Communication of Genetic Risk Information to Daughters in Families with Fragile X Syndrome: The Parent's Perspective. Journal of Genetic Counseling, 20(1), 58–69. doi:10.1007/s10897-010-9326-9.
27. Might, M., & Wilsey, M. (2014). The Shifting Model in Clinical Diagnostics: How next-Generation Sequencing and Families are Altering the way Rare Diseases are Discovered, Studied, and Treated. Genetics in Medicine, 16(10), 736–737. doi:10.1038/gim.2014.23.
28. Mikati MA J. Y, Carboni C, Shashi V, Petrovski S, Spillmann S, Milligan CJ, Li MYS, Grefe A, Berkovic S, Scheffer I, Mullen S, Bonner M, Petrou S, Goldstein DB. (2015). Quinidine in the Treatment of KCNT1 Positive Epilepsies. Annals of Neurology 78(6), 995–999. doi:10.1002/ana 24520.
29. Potter, W. J., & Levine-Donnerstein, D. (1999). Rethinking Validity and Reliability in Content Analysis. Journal of Applied Communication Research, 27, 258–284.
30. Sapp, J. C., Dong, D., Stark, C., Ivey, L. E., Hooker, G., Biesecker, L. G., & Biesecker, B. B. (2014). Parental Attitudes, Values, and Beliefs Toward the Return of Results from Exome Sequencing in Children. Clinical Genetics, 85(2), 120–126. doi:10.1111/cge.12254.
31. Shashi, V., McConkie-Rosell, A., Rosell, B., Schoch, K., Vellore, K., McDonald, M., et al. (2013). The Utility of the Traditional Medical Genetics Diagnostic Evaluation in the Context of next-Generation Sequencing for Undiagnosed Genetic Disorders. Genetics in Medicine, 16(2), 176–182. doi:10.1038/gim.2013.99.
32. Shashi, V., McConkie-Rosell, A., Schoch, K., Kasturi, V., Rehder, C., Jiang, Y. H., et al. (2015a). Practical Considerations in the Clinical Application of Whole-Exome Sequencing. Clinical Genetics. doi:10.1111/cge.12569.
33. Shashi V, Petrovski, S., Schoch K, & Crimian R, C. L., Khalid R, El-Dairi MA, Jiang YH, Mikati MA, Goldstein DB. (2015b). Sustained therapeutic response to riboflavin in a child with a progressive neurological condition, diagnosed by whole exome sequencing. Molecular Case Studies 2015. doi:10.1101/mcs.a000265
34. Tabor, H. K., Stock, J., Brazg, T., McMillin, M. J., Dent, K. M., Yu, J. H., et al. (2012). Informed consent for whole genome sequencing: a qualitative analysis of participant expectations and perceptions of risks, benefits, and harms. Am J Med Genet A, 158a(6), 1310–1319. doi:10.1002/ajmg.a.35328.
35. Yang, Y., Muzny, D. M., Reid, J. G., Bainbridge, M. N., Willis, A., Ward, P. A., et al. (2013). Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders. New England Journal of Medicine, 369(16), 1502–1511. doi:10.1056/NEJMoa1306555.
36. Yang, Y., Muzny, D. M., Xia, F., et al. (2014). Molecular Findings Among Patients Referred for Clinical Whole-Exome Sequencing. Journal of the American Medical Association. doi:10.1001/jama.2014.14601.
37. Zhu, X., Petrovski, S., Xie, P., Ruzzo, E. K., Lu, Y.-F., McSweeney, K. M., et al. (2015). Whole-Exome Sequencing in Undiagnosed Genetic Diseases: Interpreting 119 Trios. Genetics in Medicine. doi:10.1038/gim.2014.191.